Wuhan Easy Diagnosis Biomedicine Co Ltd Class A - Asset Resilience Ratio

Latest as of March 2026: 34.47%

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) has an Asset Resilience Ratio of 34.47% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 002932 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥2.07 Billion

≈ $303.62 Million USD Cash + Short-term Investments

Total Assets

CN¥6.02 Billion

≈ $880.77 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 002932 total assets.

Liquid Assets Composition Over Time

This chart breaks down Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read total liabilities of Wuhan Easy Diagnosis Biomedicine Co Ltd for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥2.07 Billion	34.47%
Total Liquid Assets	CN¥2.07 Billion	34.47%

Asset Resilience Insights

Very High Liquidity: Wuhan Easy Diagnosis Biomedicine Co Ltd Class A maintains exceptional liquid asset reserves at 34.47% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Industry Peers by Asset Resilience Ratio

Compare Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd SHE:002223	Medical Devices	0.84%
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	34.37%
Stratec SE XETRA:SBS	Medical Devices	0.29%
Shinhung KO:004080	Medical Devices	4.17%
DRTECH Corporation KQ:214680	Medical Devices	5.18%
Novacyt PA:ALNOV	Medical Devices	0.02%
Diagnostic Medical Systems SA PA:ALDMS	Medical Devices	1.48%

Annual Asset Resilience Ratio for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	6.59%	CN¥394.35 Million ≈ $57.71 Million	CN¥5.98 Billion ≈ $875.11 Million	+5.62pp
2024-12-31	0.97%	CN¥64.12 Million ≈ $9.38 Million	CN¥6.59 Billion ≈ $964.77 Million	-0.69pp
2023-12-31	1.66%	CN¥122.59 Million ≈ $17.94 Million	CN¥7.39 Billion ≈ $1.08 Billion	-19.59pp
2022-12-31	21.25%	CN¥1.95 Billion ≈ $285.75 Million	CN¥9.19 Billion ≈ $1.34 Billion	+0.76pp
2021-12-31	20.49%	CN¥700.00 Million ≈ $102.43 Million	CN¥3.42 Billion ≈ $500.03 Million	+6.47pp
2020-12-31	14.02%	CN¥200.00 Million ≈ $29.27 Million	CN¥1.43 Billion ≈ $208.76 Million	-17.31pp
2019-12-31	31.33%	CN¥200.00 Million ≈ $29.27 Million	CN¥638.42 Million ≈ $93.42 Million	--

pp = percentage points

About Wuhan Easy Diagnosis Biomedicine Co Ltd Class A

SHE:002932 China Medical Devices

Market Cap

$520.92 Million

CN¥3.56 Billion CNY

Market Cap Rank

#12140 Global

#3523 in China

Share Price

CN¥15.31

Change (1 day)

-0.07%

52-Week Range

CN¥13.85 - CN¥20.47

All Time High

CN¥49.58